MCRPC OR ADVANCED/METASTATIC SOLID TUMORS
Clinical trials for MCRPC OR ADVANCED/METASTATIC SOLID TUMORS explained in plain language.
Never miss a new study
Get alerted when new MCRPC OR ADVANCED/METASTATIC SOLID TUMORS trials appear
Sign up with your email to follow new studies for MCRPC OR ADVANCED/METASTATIC SOLID TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Triple-Action drug takes on Hard-to-Treat cancers
Disease control Recruiting nowThis early-phase study tests a new drug called HLX3902 in about 48 people with advanced prostate cancer or other solid tumors that have stopped responding to standard treatments. The main goal is to check the drug's safety and find the best dose. The drug is designed to help the …
Matched conditions: MCRPC OR ADVANCED/METASTATIC SOLID TUMORS
Phase: PHASE1 • Sponsor: Shanghai Henlius Biotech • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Can a new daily pill slow advanced prostate cancer?
Disease control Recruiting nowThis early-stage trial tests whether an experimental drug called FX-111 is safe enough to study further in men with metastatic castration-resistant prostate cancer (mCRPC), a form of advanced prostate cancer that no longer responds to standard hormone therapy. Participants take F…
Matched conditions: MCRPC OR ADVANCED/METASTATIC SOLID TUMORS
Phase: PHASE1 • Sponsor: Flare Therapeutics Inc. • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC